Evidence map›Paper›PMID 30867451›Full record

ArticleScientific reports2019

Cationic gold nanoparticles elicit mitochondrial dysfunction: a multi-omics study.

Audrey Gallud, Katharina Klöditz, Jimmy Ytterberg, Nataliya Östberg, Shintaro Katayama, Tiina Skoog, Vladimir Gogvadze, Yu-Zen Chen, Ding Xue, Sergio Moya and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Safety Landscape of Therapeutic Nanozymes and Future Research Directions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Understanding the immunological interactions of engineered nanomaterials: Role of the bio-corona.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Audrey GalludNanosafety & Nanomedicine Laboratory, Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.ORCID 0000-0003-0283-4028
Katharina KlöditzNanosafety & Nanomedicine Laboratory, Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.
Jimmy YtterbergDepartment of Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.
Nataliya ÖstbergDepartment of Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.
Shintaro KatayamaDepartment of Biosciences & Nutrition, Karolinska Institutet, 141 83, Huddinge, Sweden.
Tiina SkoogDepartment of Biosciences & Nutrition, Karolinska Institutet, 141 83, Huddinge, Sweden.ORCID 0000-0002-0148-0654
Vladimir GogvadzeDivision of Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden.
Yu-Zen ChenDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO, 80309, USA.
Ding XueDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO, 80309, USA.
Sergio MoyaCICbiomaGUNE, 20009, San Sebastian, Spain.
Jaime RuizISM, UMR CNRS 5255, Université de Bordeaux, 33405, Talence, France.
Didier AstrucISM, UMR CNRS 5255, Université de Bordeaux, 33405, Talence, France.
Roman ZubarevDepartment of Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden.
Juha KereDepartment of Biosciences & Nutrition, Karolinska Institutet, 141 83, Huddinge, Sweden.ORCID 0000-0003-1974-0271
Bengt FadeelNanosafety & Nanomedicine Laboratory, Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77, Stockholm, Sweden. Bengt.Fadeel@ki.se.

Funding

Fundamental mechanisms of paternal mitochondrial eliminationand radiation-induced bystander effectsR35GM118188 · NIGMS · UNIVERSITY OF COLORADO · PI DING XUE · 2016 to 2026
$6.8M
NIGMS NIH HHS R35 GM118188
6 · The paper itself

Abstract

Systems biology is increasingly being applied in nanosafety research for observing and predicting the biological perturbations inflicted by exposure to nanoparticles (NPs). In the present study, we used a combined transcriptomics and proteomics approach to assess the responses of human monocytic cells to Au-NPs of two different sizes with three different surface functional groups, i.e., alkyl ammonium bromide, alkyl sodium carboxylate, or poly(ethylene glycol) (PEG)-terminated Au-NPs. Cytotoxicity screening using THP-1 cells revealed a pronounced cytotoxicity for the ammonium-terminated Au-NPs, while no cell death was seen after exposure to the carboxylated or PEG-modified Au-NPs. Moreover, Au-NR3+ NPs, but not the Au-COOH NPs, were found to trigger dose-dependent lethality in vivo in the model organism, Caenorhabditis elegans. RNA sequencing combined with mass spectrometry-based proteomics predicted that the ammonium-modified Au-NPs elicited mitochondrial dysfunction. The latter results were validated by using an array of assays to monitor mitochondrial function. Au-NR3+ NPs were localized in mitochondria of THP-1 cells. Moreover, the cationic Au-NPs triggered autophagy in macrophage-like RFP-GFP-LC3 reporter cells, and cell death was aggravated upon inhibition of autophagy. Taken together, these studies have disclosed mitochondria-dependent effects of cationic Au-NPs resulting in the rapid demise of the cells.

Indexed as

Metal NanoparticlesAmmonium CompoundsAutophagyCationsCell DeathCell Line, TumorChemical PhenomenaDose-Response Relationship, DrugGene Expression ProfilingGoldHumansMetabolic Networks and PathwaysMitochondriaOxidative PhosphorylationProteomeProteomicsAmmonium CompoundsCationsGoldProteome

Identifiers

PMID30867451
PMCPMC6416392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.